homeWelcome, sign in or click here to subscribe.login
     


 

 

Business


print  email to a friend  reprints add to mydjc  

December 6, 2019

Omeros

Seattle-based biopharmaceutical company Omeros announced it will issue $50 million in common stock priced at $13.10 per share. The offering is expected to close on Dec. 9. Omeros intends to use the proceeds for general corporate purposes, including funding clinical trials, pre-clinical studies, manufacturing and build-out of commercial infrastructure. Cantor Fitzgerald & Co. is managing the stock offering.




Email or user name:
Password:
 
Forgot password? Click here.